SANF

Sanofi News

Kaufen
Verkaufen
Best deals to access real time data!
Italian Stock Exchange
Monthly Subscription
for only
14,77 €
Italienische Börse Level 2
Monthly Subscription
for only
26,39 €
VAT not included
Name Symbol Markt Aktientyp
Sanofi SANF Italien Ordinary Share
  Änderung Änderung % Aktuell Zeit
0,37 0,43% 85,77 17:29:59
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
85,85 85,65 86,08 85,77 85,40
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.10.202107:00GLOBESecond Dupixent® (dupilumab) Phase 3 eosinophilic..
22.10.202107:00GLOBEDupixent® (dupilumab) – premier médicament biologique ayant..
20.10.202123:30GLOBEFDA expands approval of Dupixent® (dupilumab) to include..
13.10.202109:00GLOBEPrésentation à l’ECTRIMS 2021 de nouvelles données à long..
01.10.202120:28GLOBESanofi: Information concerning the total number of voting..
30.9.202114:30GLOBENew, late-breaking data at EADV highlights emerging clinical..
28.9.202108:00GLOBESanofi annonce des résultats intermédiaires positifs de..
24.9.202107:30GLOBESanofi: Availability of the Q3 2021 Memorandum for modelling..
21.9.202107:00GLOBENew Dupixent® (dupilumab) data in patients as young as 6..
19.9.202117:30GLOBEESMO late-breaking data show Libtayo® (cemiplimab) and..
14.9.202115:26GLOBESanofi finalise l’acquisition de Translate Bio et accélère..
09.9.202107:00GLOBESanofi fait le point sur l’étude de phase III consacrée au..
08.9.202114:08GLOBESanofi to acquire Kadmon to further strengthen growth of..
08.9.202107:00GLOBESanofi va acquérir Kadmon pour renforcer la croissance de..
30.8.202107:00GLOBEUn essai pivot consacré à Dupixent (dupilumab) atteint tous..
25.8.202118:31GLOBESanofi: Information concerning the total number of voting..
06.8.202117:42GLOBELa FDA approuve Nexviazyme® (avalglucosidase alpha-ngpt),..
05.8.202112:00GLOBEPhase 3 trial of Libtayo® (cemiplimab) combined with..
03.8.202107:00GLOBESanofi to acquire Translate Bio; advances deployment of mRNA..
29.7.202118:24GLOBEMise en ligne du rapport financier semestriel 2021 de Sanofi
29.7.202107:31GLOBESanofi nomme deux nouveaux dirigeants au Comité Exécutif et..
29.7.202107:30GLOBEAccélération des ventes - Perspectives 2021 revues à la..
29.7.202107:00GLOBEDupixent®(dupilumab) améliore significativement les..
22.7.202118:02GLOBESanofi: Information concerning the total number of voting..
13.7.202107:30GLOBESanofi announces Paris 2024 Premium partnership for the..
30.6.202118:00GLOBESanofi: Informations relatives au nombre de droits de vote..
29.6.202110:00GLOBESanofi launches dedicated vaccines mRNA Center of Excellence
28.6.202108:00GLOBENirsevimab shows positive topline results in RSV Phase 2/3..
28.6.202107:00GLOBEDupixent® (dupilumab) SmPC updated with long-term data..
25.6.202107:30GLOBESanofi: Availability of the Q2 2021 Memorandum for modelling..
25.6.202107:15GLOBESanofi: Libtayo® (cemiplimab) approved by the European..
25.6.202107:00GLOBESanofi: Libtayo® (cemiplimab) approved by the European..
18.6.202115:45GLOBEEuropean Commission approves Aubagio® (teriflunomide) as the..
11.6.202109:00GLOBENew pivotal data at EHA 2021 reinforces sutimlimab as a..
07.6.202118:00GLOBESanofi launches its new global employee share ownership plan
04.6.202107:00GLOBESanofi partnering with leading academic cooperative groups..
03.6.202114:00GLOBESanofi launches €3 million Planet Mobilization fund to..
01.6.202107:00GLOBESanofi fait le point sur le programme clinique consacré au..
31.5.202118:00GLOBESanofi : Informations relatives au nombre total de droits de..
27.5.202107:30GLOBESanofi and GSK initiate global Phase 3 clinical efficacy..
19.5.202123:45GLOBESanofi va présenter les résultats de ses recherches..
19.5.202123:00GLOBEEarly amcenestrant data featured at ASCO support its..
17.5.202116:00GLOBEPivotal data at ATS 2021 show Dupixent® (dupilumab)..
17.5.202107:30GLOBEL’essai de phase II du candidat-vaccin contre la COVID-19 de..
06.5.202107:00GLOBESanofi establishes three-year collaboration with Stanford..
03.5.202118:00GLOBESanofi: Information concerning the total number of voting..
30.4.202117:56GLOBEAssemblée Générale Annuelle du 30 avril 2021
28.4.202107:30GLOBESanofi continued its growth trajectory. Strong increase in..
26.4.202108:00GLOBEUn essai de phase III montre que le nirsevimab protège les..
23.4.202116:05GLOBEDe nouvelles analyses des données relatives à Dupixent®..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
BIT
SANF
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20211027 01:37:23